PDGFRα and αSMA mark two distinct mesenchymal cell populations involved in parenchymal and vascular remodeling in pulmonary fibrosis
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA521308 | ENA |
REPOSITORIES: ENA
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| SRR8543860.fastq.gz | Fastqsanger.gz | |||
| SRR8543870.fastq.gz | Fastqsanger.gz | |||
| SRR8543880.fastq.gz | Fastqsanger.gz | |||
| SRR8543851.fastq.gz | Fastqsanger.gz | |||
| SRR8543861.fastq.gz | Fastqsanger.gz |
Items per page: 5 1 - 5 of 32 |
Similar Datasets
Project description:We utilized a fate-mapping approach to investigate alpha-smooth muscle actin (αSMA)+ and platelet derived growth factor-alpha (PDGFRα)+ cells in two lung fibrosis models, complemented by cell-type specific next-generation sequencing and investigations on human lungs. Our data revealed that αSMA+ and PDGFRα+ cells mark two distinct mesenchymal lineages with minimal transdifferention potential during lung fibrotic remodeling. Parenchymal and perivascular fibrotic regions were populated predominantly with PDGFRα+ cells expressing collagen, while αSMA+ cells in the parenchyma and vessel wall showed variable expression of collagen and the contractile protein desmin. The distinct gene expression profiles found in normal conditions was retained during pathologic remodeling. Cumulatively, our findings identify αSMA+ and PDGFRα+ cells as two separate lineages with distinct gene expression profile in adult lungs.
2019-02-08 | GSE126205 | GEO
Project description: Not available
| S-EPMC7189793 | biostudies-literature
Project description:Expression data of PDGFRα- and PDGFRα+ mesenchymal stem cells isolated from mouse periosteum
| PRJNA644793 | ENA
Project description:The platelet-derived growth factor receptor alpha (PDGFRα) exhibits divergent effects in skeletal muscle. At physiological levels, signaling through this receptor promotes muscle development in growing embryos and proper angiogenesis in regenerating adult muscle. However, either increased PDGF ligands or enhanced PDGFRα pathway activity causes pathological fibrosis. This excessive collagen deposition, which is seen in aged and diseased muscle, interferes with proper muscle function and limits the effectiveness of gene- and cell-based therapies for muscle disorders. Although compelling evidence exists for the role of PDGFRα in fibrosis, little is known about the cells through which this pathway acts. Here we show that PDGFRα signaling regulates a population of muscle-resident fibro/adipogenic progenitors (FAPs) that play a supportive role in muscle regeneration but may also cause fibrosis when aberrantly regulated. We found that FAPs produce multiple transcriptional variants of PDGFRα with different polyadenylation sites, including an intronic variant that codes for a protein isoform containing a truncated kinase domain. This variant, upregulated during regeneration, acts as a decoy to inhibit PDGF signaling and to prevent FAP over-activation. Moreover, increasing expression of this isoform limits fibrosis in vivo, suggesting both biological relevance and therapeutic potential of modulating polyadenylation patterns in stem cell populations. We used microarrays to explore the biological effects of altering intronic polyadenylation of PDGFRα in FAPs in vivo.
2016-11-30 | GSE81744 | GEO
Project description:The platelet-derived growth factor receptor alpha (PDGFRα) exhibits divergent effects in skeletal muscle. At physiological levels, signaling through this receptor promotes muscle development in growing embryos and proper angiogenesis in regenerating adult muscle. However, either increased PDGF ligands or enhanced PDGFRα pathway activity causes pathological fibrosis. This excessive collagen deposition, which is seen in aged and diseased muscle, interferes with proper muscle function and limits the effectiveness of gene- and cell-based therapies for muscle disorders. Although compelling evidence exists for the role of PDGFRα in fibrosis, little is known about the cells through which this pathway acts. Here we show that PDGFRα signaling regulates a population of muscle-resident fibro/adipogenic progenitors (FAPs) that play a supportive role in muscle regeneration but may also cause fibrosis when aberrantly regulated. We found that FAPs produce multiple transcriptional variants of PDGFRα with different polyadenylation sites, including an intronic variant that codes for a protein isoform containing a truncated kinase domain. This variant, upregulated during regeneration, acts as a decoy to inhibit PDGF signaling and to prevent FAP over-activation. Moreover, increasing expression of this isoform limits fibrosis in vivo, suggesting both biological relevance and therapeutic potential of modulating polyadenylation patterns in stem cell populations. We used microarrays to explore the biological effects of altering intronic polyadenylation of PDGFRα in FAPs.
2016-11-30 | GSE60099 | GEO
Project description:Limb development begins with limb buds that develop into long appendicular bones separated by joint-forming structures called interzones. Mesenchymal progenitor cells of the interzone differentiate into cartilaginous and fibrous tissues of the synovial joint, including articular cartilage, menisci, and ligaments. Platelet-derived growth factor receptor-α (PDGFRα) is expressed by mesenchymal cells of the limb bud, but it is not known to have a role in limb or joint development. By analyzing PDGFRα expression in single-cell RNA sequencing data, immunofluorescence, and lineage tracing, we observed dynamic PDGFRα expression in the mouse limb bud, interzone, and perichondral mesenchyme. To investigate PDGFRα function, we use Prrx1-Cre to cause mouse limb bud mesenchyme to express mutant PDGFRα with a kinase domain point mutation (D842V) that increases receptor signaling. Overall limb development was unaffected. However, the hind limbs were immobile with knee joints fused by cartilage and lacking ligaments and menisci. The mutant perichondrium exhibited ectopic cartilage matrix and the enthesis of the patellar tendon was enlarged. The interzone marker Gdf5 was initially expressed at E12.5 but was downregulated at E13.5 and thereafter, suggesting a defect in maintenance of the interzone. Spatial transcriptomics of the mutant joint identified co-expression of genes for both cartilage (Sox9, Col2a1) and fibrotic tissue (Postn, Col1a1, Col1a2), suggesting fibrocartilage. These data suggest that elevated PDGFRα signaling corrupts joint tissue differentiation by downregulating Gdf5 and redirecting interzone progenitors into a fibrocartilage fate. These results highlight the need to balance chondrogenic and fibrogenic cell fates during joint development, with tight regulation of PDGFRα signaling as a necessity for the development of the mouse knee joint.
2025-04-01 | GSE289873 | GEO
Project description:PDGFRα+ cells are interstitial/perivascular mesenchymal progenitor cells that have been associated with fibro-adipogenic processes. However, their function during tissue homeostasis or in response to revascularization and regeneration stimuli remains to be fully defined. Here, by high-throughput transcriptomic analysis, adoptive transfer and multicolor lineage tracking we showed that PDGFRα+ cells from skeletal muscle cluster as a population that is transcriptionally distinct from other mesenchymal stromal cells and with an essential role in tissue revascularization and restructuring of ischemic areas. We further showed that tissue regeneration involves the removal of differentiated PDGFRα+-derived cells, while pathological healing occurred if PDGFRα+-derived cells persisted as terminally differentiated mesenchymal cells (e.g. myofibroblasts). From the perspective of tissue regeneration, these studies support a context-dependent 'yin-yang' biology of PDGFRα+ cells, that possess an innate ability to stabilize newly formed blood vessels and concurrently limit injury expansion after ischemia, while also being capable of promoting fibrosis in an unfavorable environment.
2019-07-01 | GSE101930 | GEO
Project description:Limb development begins with limb buds that develop into long appendicular bones separated by joint-forming structures called interzones. Mesenchymal progenitor cells of the interzone differentiate into cartilaginous and fibrous tissues of the synovial joint, including articular cartilage, menisci, and ligaments. Platelet-derived growth factor receptor-α (PDGFRα) is expressed by mesenchymal cells of the limb bud, but it is not known to have a role in limb or joint development. By analyzing PDGFRα expression in single-cell RNA sequencing data, immunofluorescence, and lineage tracing, we observed dynamic PDGFRα expression in the mouse limb bud, interzone, and perichondral mesenchyme. To investigate PDGFRα function, we use Prrx1-Cre to cause mouse limb bud mesenchyme to express mutant PDGFRα with a kinase domain point mutation (D842V) that increases receptor signaling. Overall limb development was unaffected. However, the hind limbs were immobile with knee joints fused by cartilage and lacking ligaments and menisci. The mutant perichondrium exhibited ectopic cartilage matrix and the enthesis of the patellar tendon was enlarged. The interzone marker Gdf5 was initially expressed at E12.5 but was downregulated at E13.5 and thereafter, suggesting a defect in maintenance of the interzone. Spatial transcriptomics of the mutant joint identified co-expression of genes for both cartilage (Sox9, Col2a1) and fibrotic tissue (Postn, Col1a1, Col1a2), suggesting fibrocartilage. These data suggest that elevated PDGFRα signaling corrupts joint tissue differentiation by downregulating Gdf5 and redirecting interzone progenitors into a fibrocartilage fate. These results highlight the need to balance chondrogenic and fibrogenic cell fates during joint development, with tight regulation of PDGFRα signaling as a necessity for the development of the mouse knee joint.
2025-04-01 | GSE289874 | GEO
Project description:Glioblastoma multiforme (GBM) is an aggressive primary brain cancer that includes focal amplification of PDGFRα and for which there are no effective therapies. Herein, we report the development of a genetically engineered mouse model of GBM based on autocrine, chronic stimulation of PDGFRα and the analysis of GBM signaling pathways using proteomics. We discovered the tubulin-binding protein Stathmin1 (STMN1) as a PDGFRα phospho-regulated target and that this mis-regulation conferred selective sensitivity to vinblastine (VB) cytotoxicity. Treatment of PDGFRα GBMs with VB in mice drastically prolonged survival and was dependent on STMN1. Our work provides a rationale for evaluating genotype-specific anti-microtubule drugs as cancer treatment in select GBM patient populations.
2018-05-15 | GSE114438 | GEO
Project description:Genomic copy number profiling of TAK1 deficient liver parenchymal cells with Rip3 double knockout Sample vs. Reference (pool of 4 normal liver tissues)
2013-05-01 | E-GEOD-45206 | biostudies-arrayexpress